Influence of the treatment with recombinant human erythropoietin on plasma concentration of interleukin-1-alpha and tumour necrosis factor-alpha in hemodialyzed subjects.
Buemi
M
M
Allegra
A
A
Aloisi
C
C
Privitera
M
M
Morabito
N
N
Frisina
N
N
D000740:Anemia / Q000097:blood / Q000188:drug therapy; D004921:Erythropoietin / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007375:Interleukin-1 / Q000097:blood*; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
D007375:Interleukin-1; D014409:Tumor Necrosis Factor-alpha; D004921:Erythropoietin